<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0304221908
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2003
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        PROTON 20MG E.C TABLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        PANTOPRAZOLE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Enteric-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        28
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        48.60
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="SPIMACO" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            SPIMACO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 488]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SPIMACO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SPIMACO ADDWAEIH
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A02BC02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>PROTON 20 mg contains the active substance pantoprazole.&nbsp;Proton 20 mg is a selective &ldquo;proton pump inhibitor&rdquo;, a medicine which reduces the amount of acid produced in your stomach. It is used for treating acid-related diseases of the stomach and intestine.</p><p>&nbsp;</p><p>Proton is used:</p><p><strong>Adult and adolescents 12 years of age and above</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; To treat symptoms (e.g. heartburn, acid regurgitation, pain on swallowing) associated with gastro-oesophageal reflux disease caused by reflux of acid from the stomach.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For the long-term management and prevention of reflux oesophagitis (inflammation of the oesophagus accompanied by the regurgitation of stomach acid) and preventing its return.</p><p>&nbsp;</p><p><strong>Adults</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For the prevention of stomach and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs), e.g. ibuprofen in patients at risk who need to take NSAIDs continuously.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Proton 20 mg</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are allergic (hypersensitive) to pantoprazole or any of the other ingredients of Proton 20 mg (see section 6).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are allergic to medicines containing other proton pump inhibitors.</p><p>&nbsp;</p><p><strong>Take special care with Proton 20 mg</strong></p><p><strong>&nbsp;</strong></p><p>Talk to your doctor, pharmacist or nurse before taking PROTON 20 mg</p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have severe liver problems. Please tell your doctor if you have ever had problems with your liver. He will check your liver enzymes more frequently, especially when you are taking Proton 20 mg as a long-term treatment. If the liver enzyme levels increase, then treatment should be stopped.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you need to take medicines called NSAIDs continuously and are prescribed Proton 20 mg because you have an increased risk of developing stomach and intestinal complications. Any increased risk will be assessed according to your own personal risk factors such as your age (65 years old or more), a history of stomach or duodenal ulcers or of stomach or intestinal bleeding.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have reduced body stores or risk factors for reduced vitamin B12 and receive Proton as a long-term treatment. As with all acid reducing agents, Proton may lead to a reduced absorption of vitamin B12.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are taking HIV protease inhibitors such as atazanavir (for the treatment of HIV-infection) at the same time as Proton, ask your doctor for specific advice.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Taking a proton pump inhibitor like Proton, especially over a period of more than one year, may slightly increase your risk of fracture in the hip, wrist or spine. Tell your doctor if you have osteoporosis or if you are taking corticosteroids (which can increase the risk of osteoporosis).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are on Proton for more than three months it is possible that the levels of magnesium in your blood may fall. Low levels of magnesium can be seen as fatigue, involuntary muscle contractions, disorientation, convulsions, dizziness, increased heart rate. If you get any of these symptoms, please tell your doctor promptly. Low levels of magnesium can also lead to a reduction in potassium or calcium levels in the blood. Your doctor may decide to perform regular blood tests to monitor your levels of magnesium.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have ever had a skin reaction after treatment with a medicine similar to Proton that reduces stomach acid.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you get a rash on your skin, especially in areas exposed to the sun tell your doctor as soon as you can, as you may need to stop your treatment with Proton. Remember to also mention any other ill-effects like pain in your joints.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are due to have a specific blood test (Chromogranin A).</p><p><strong>&nbsp;</strong></p><p><strong>Tell your doctor immediately,</strong> before or after taking this medicine, if you notice any of the following symptoms, which could be a sign of another, more serious, disease:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An unintentional loss of weight.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vomiting, particularly if repeated.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vomiting blood; this may appear as dark coffee grounds in your vomit.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You notice blood in your stools; which may be black or tarry in appearance.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Difficulty in swallowing or pain when swallowing.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You look pale and feel weak (anaemia).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chest pain.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stomach pain.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe and/or persistent diarrhoea, as Proton 20 mg has been associated with a small increase in infectious diarrhoea.</p><p>Your doctor may decide that you need some tests to rule out malignant disease because Proton also alleviates the symptoms of cancer and could cause delay in diagnosing it.</p><p>If your symptoms continue in spite of your treatment, further investigations will be considered.</p><p>If you take Proton 20 mg on a long-term basis (longer than 1 year) your doctor will probably keep you under regular surveillance. You should report any new and exceptional symptoms and circumstances whenever you see your doctor.</p><p>&nbsp;</p><p><strong>Children and adolescents</strong></p><p>Proton 20 mg is not recommended for use in children as it has not been proven to work in children below 12 years of age.</p><p>&nbsp;</p><p><strong>Taking other medicines:</strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.</p><p>&nbsp;</p><p>This is because Proton 20 mg may influence the effectiveness of other medicines, so tell your doctor if you are taking:</p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines such as ketoconazole, itraconazole, and posaconazole (used to treat fungal infections) or erlotinib (used for certain types of cancer) because PROTON 20 mg may stop these and other medicines from working properly.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Warfarin and phenprocoumon, which affect the thickening or thining of the blood. You may need further checks.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines used to treat HIV-infection, such as atazanavir.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Methotrexate (used to treat rheumatoid arthritis, psoriasis, and cancer) &ndash; if you are taking methotrexate your doctor may temporarily stop your Proton 20 mg treatment because pantoprazole can increase levels of methotrexate in the blood.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fluvoxamine (used to treat depression and other psychiatric diseases) &ndash; if you are taking fluvoxamine your doctor may reduce the dose.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rifampicin (used to treat infections).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; St John&rsquo;s wort (Hypericum perforatum) (used to treat mild depression).</p><p><strong>&nbsp;</strong></p><p><strong>Pregnancy and breast-feeding</strong></p><p>There are no adequate data from the use of pantoprazole in pregnant women. Excretion into human milk has been reported.</p><p>&nbsp;</p><p>If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p>&nbsp;</p><p>You should use this medicine, only if your doctor considers the benefit for you greater than the potential risk for your unborn child or baby.</p><p><strong>&nbsp;</strong></p><p><strong>Driving and using machines</strong></p><p>PROTON 20 mg has no or negligible influence on the ability to drive and use machines.</p><p>If you experience side effects like dizziness or disturbed vision, you should not drive or operate machinery.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Proton 20 mg exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</p><p><strong>&nbsp;</strong></p><p><strong>Method of administration</strong></p><p>&nbsp;</p><p>Take the tablets 1 hour before a meal, without chewing or breaking them, and swallow them whole with some water.</p><p>&nbsp;</p><p>The recommended dose is:</p><p><strong>Adults and adolescents 12 years of age and above</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>To treat symptoms (e.g. heartburn, acid regurgitation, pain on swallowing) associated to gastro-oesophageal reflux disease </strong></p><p>The usual dose is one tablet a day. This dose usually brings relief within 2 - 4 weeks &ndash; at most after another 4 weeks. Your doctor will tell you how long to continue taking the medicine. After this any recurring symptoms can be controlled by <strong>taking one tablet daily, </strong>when required.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>For long-term management and for preventing the return of reflux oesophagitis</strong></p><p>The usual dose is one tablet a day. If the illness returns, your doctor can double the dose, in which case you can use Proton 40 mg tablets instead, one a day. After healing, you can reduce the dose back again to one tablet Proton 20 mg a day.</p><p>&nbsp;</p><p><strong>Adults</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>To prevent duodenal and stomach ulcers in patients who need to take NSAIDs continuously</strong></p><p>The usual dose is one tablet a day.</p><p>&nbsp;</p><p><strong>Patients with liver problems</strong></p><p>If you suffer from severe liver problems, you should not take more than one 20 mg tablet a day.</p><p>&nbsp;</p><p><strong>Use in children and adolescents</strong></p><p>These tablets are not recommended for use in children below 12 years.</p><p>&nbsp;</p><p><strong>If you take more Proton 20 mg than you should</strong></p><p>Tell your doctor or pharmacist. There are no known symptoms of overdose.</p><p>&nbsp;</p><p><strong>If you forget to take Proton 20 mg</strong></p><p>Do not take a double dose to make up for a forgotten dose. Take your next normal dose at the usual time.</p><p>&nbsp;</p><p><strong>If you stop taking Proton 20 mg</strong></p><p>Do not stop taking these tablets without first talking to your doctor or pharmacist.</p><p>&nbsp;</p><p>If you have any further questions about the use of this product, ask your doctor, pharmacist, or nurse.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Proton 20 mg can cause side effects, although not everybody gets them.</p><p><strong>&nbsp;</strong></p><p><strong>If you get any of the following side effects, stop taking these tablets and tell your doctor immediately, or contact the casualty department at your nearest hospital:</strong></p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Serious allergic reactions (frequency rare:&nbsp;</strong>may affect up to 1 in 1,000 people<strong>): </strong>swelling of the tongue and/or throat, difficulty in swallowing, hives (nettle rash), difficulties in breathing, facial swelling (Quincke&rsquo;s oedema / angioedema), severe dizziness with very fast heartbeat and heavy sweating.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Serious skin conditions (frequency not known: </strong>frequency cannot be estimated from the available data<strong>): </strong>blistering of the skin and rapid deterioration of your general health, blistering (including slight bleeding) of eyes, nose, mouth/lips or genitals (Stevens-Johnson-Syndrome, Lyell-Syndrome, Erythema multiforme) and sensitivity to light.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other serious conditions (frequency not known: </strong>frequency cannot be estimated from the available data<strong>): </strong>yellowing of the skin or whites of the eyes (severe damage to liver cells, jaundice) or fever, rash, and enlarged kidneys sometimes with painful urination and lower back pain (serious inflammation of the kidneys), possibly leading to kidney failure.</p><p>Other side effects are:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Common</strong>&nbsp;(may affect up to 1 in 10 people)<br />Benign polyps in the stomach.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Uncommon </strong>(may affect up to 1 in 100 people)</p><p>Headache; dizziness; diarrhoea; feeling sick, vomiting; bloating and flatulence (wind); constipation; dry mouth; abdominal pain and discomfort; skin rash, exanthema, eruption; itching; feeling weak, exhausted or generally unwell; sleep disorders, fracture of the hip, wrist or spine.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Rare </strong>(may affect up to 1 in 1,000 people)</p><p>Distortion or complete lack of the sense of taste; disturbances in vision such as blurred vision; hives; pain in the joints; muscle pains; weight changes; raised body temperature; swelling of the extremities (peripheral oedema); allergic reactions; depression; breast enlargement in males.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Very Rare </strong>(may affect up to 1 in 10,000 people)<strong> </strong></p><p>Disorientation.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Not known </strong>(frequency cannot be estimated from the available data)</p><p>Hallucination, confusion (especially in patients with a history of these symptoms); decreased sodium level in blood, decreased magnesium level in blood (see section 2), feeling of tingling, prickling, pins and needles, burning sensation or numbness, rash, possibly with pain in the joints, inflammation in the large bowel, that causes persistent watery diarrhoea.</p><p><strong>&nbsp;</strong></p><p><strong>Side effects identified through blood tests:</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Uncommon </strong>(may affect up to 1 in 100 people)</p><p>An increase in liver enzymes.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Rare </strong>(may affect up to 1 in 1,000 people)</p><p>An increase in bilirubin; increased fats in the blood; sharp drop in circulating granular white blood cells, associated with high fever.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Very Rare </strong>(may affect up to 1 in 10,000 people)</p><p>A reduction in the number of blood platelets, which may cause you to bleed or bruise more than normal; a reduction in the number of white blood cells, which may lead to more frequent infections; coexisting abnormal reduction in the number of red and white blood cells, as well as platelets.</p><p>&nbsp;</p><p>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</p><p>&nbsp;</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via The National Pharmacovigilance and Drug Safety Centre (NPC). By reporting side affects you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep out of the reach and sight of children.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Store below 30&ordm;C.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use this medicine after the expiry date which is stated on the carton and the bottle label after EXP. The expiry date refers to the last day of that month.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Proton 20 mg contains:</strong></p><p>The active substance is: pantoprazole.</p><p>Each enteric coated tablet contains 20 mg of pantoprazole (as pantoprazole sodium).</p><p>The other ingredients are:</p><p><strong>Tablet core</strong></p><p>Mannitol BP, Crospovidone, Sodium Carbonate Decahydrate BP, Povidone K-90, Calcium Stearate USP, Purified Water BP.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p><strong>Tablet coating</strong></p><p>Hydroxypropyl Methyl Cellulose, Povidone K-25, Titanium Dioxide, Iron Oxide Yellow, Propylene Glycol , Eudragit L30D (30% SOLN), Triethyl Citrate USP, Purified Talc, Purified Water BP&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p><strong>Polishing:</strong></p><p>Carnauba Wax.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Proton 20 mg Beige colored, oval, shallow biconvex, enteric coated tablet, plain on both sides. Available in packs of 14 and 28 tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>SPIMACO </strong></p><p>Al-Qassim Pharmaceutical Plant.</p><p>Saudi Arabia.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                September 2023.                                           
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">بروتون 20 ملجم<strong> </strong>يحتوي على المادة الفعالة بانتوبرازول. <strong>&nbsp;</strong>بروتون 20 ملجم هو &quot;مثبط لمضخة البروتون&quot;، وهو دواء يقلل من كمية الحامض المفرزة فى المعدة. فهو يستخدم لعلاج الأمراض المتعلقة بالحامض والتى تصيب المعدة والأمعاء.</p><p dir="RTL">يستخدم بروتون:</p><p dir="RTL"><strong>فى حالة البالغين والمراهقين فى سن 12 سنة فما أكثر </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لعلاج بعض الأعراض (مثل حرقة الفؤاد، ارتجاع الحامض، الألم المصاحب للبلع) المرتبطة بمرض الارتجاع المعدي المريئى والذي يسببه ارتجاع الحامض من المعدة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لعلاج طويل المدى للسيطرة والحد من الالتهاب المريئى الناتج عن الارتجاع (وهو التهاب المرئ المصاحب لارتجاع الحامض من المعدة) والحد من تكراره.</p><p dir="RTL">&nbsp;<strong>فى البالغين</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كعلاج للحد من تقرحات المعدة والإثنى عشر الناتجة عن استخدام مضادات الالتهاب غير الإستيرويدية (NSAIDs)، مثل إيبوبرفين في حالة المرضى المحتاجين لتناول NSAIDs بشكل مستمر.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تقم بتناول بروتون في الحالات الآتية:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من فرط التحسس تجاه مادة بانتوبرازول أو أى من المكونات الأخرى لأقراص بروتون 20 ملجم (انظر فقرة 6).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من فرط التحسس تجاه أدوية تحتوي على مثبطات أخرى لمضخة البروتون.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>ينبغى توخى الحذر عند تناول بروتون 20 ملجم فى الحالات الآتية:</strong></p><p dir="RTL">تحدث إلى طبيبك أو الصيدلي أو الممرضة قبل تناول بروتون 20 ملجم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابا بمشاكل حادة بالكبد. يرجى إخبار طبيبك المعالج إذا كانت لديك في أي وقت مضى مشاكل في الكبد. حيث سيقوم الطبيب المعالج بفحص إنزيمات الكبد لديك بشكل متكرر، خصوصا في حالة تناولك لأقراص بروتون 20 ملجم كعلاج طويل المدى. في حالة ازدياد مستوى إنزيمات الكبد، يجب التوقف عن تناول العلاج.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت في احتياج لتناول أدوية تسمى NSAIDs باستمرار وقد وصف لك بروتون 20 ملجم بسبب أنك أكثر عرضة للإصابة بمضاعفات فى المعدة والأمعاء. حيث أن أى ازدياد فى معدل الخطورة سيتم تقييمه استنادا على عوامل الخطورة الخاصة بحالتك مثل عمرك على سبيل المثال (إذا كان عمرك 65 سنة أو أكثر) أو لديك تاريخ من تقرحات المعدة أو الإثنى عشر أو نزيف من المعدة أو الأمعاء.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا تعرضت لانخفاض مخزون الجسم من فيتامين ب 12 أو تعرضت لعوامل خطر انخفاض مستوى فيتامين ب 12 مع تناولك لأقراص بروتون كعلاج طويل المدى. حيث أن بروتون قد يؤدى إلى انخفاض في امتصاص فيتامين ب 12، كما هو الحال في جميع الأدوية الخافضة للحامض.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتناول مثبطات للإنزيم البروتيني الخاص بفيروس نقص المناعة البشرية مثل أتازانافير (والذي يستخدم لعلاج العدوى بفيروس نقص المناعة البشرية) في نفس فترة تناولك ل بروتون، قم باستشارة طبيبك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; استخدام مثبطات مضخة البروتون مثل بروتون، وخاصةً على مدى فترة تزيد عن سنة واحدة، قد يزيد قليلاً من خطر الإصابة بكسور في الورك أو الرسغ أو العمود الفقري. أخبر طبيبك المعالج إذا كان لديك مرض هشاشة العظام أو إذا كنت تستخدم كورتيزون (والذي يمكن أن يزيد من خطر هشاشة العظام).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا قمت باستخدام بروتون لأكثر من ثلاثة أشهر، فمن المحتمل أن تنخفض لديك مستويات الماغنيسيوم في الدم. ويمكن أن تظهر أعراض انخفاض مستويات الماغنيسيوم في صورة إرهاق، انقباضات عضلية لا إرادية، ارتباك، تشنجات، دوار، زيادة معدل ضربات القلب. إذا أصبت بأي من هذه الأعراض، يرجى إخبار طبيبك على الفور. يمكن أن يؤدي انخفاض مستويات الماغنيسيوم أيضًا إلى انخفاض مستويات البوتاسيوم أو الكالسيوم في الدم. قد يقرر طبيبك إجراء اختبارات دم منتظمة لمراقبة مستويات الماغنيسيوم لديك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت قد عانيت في أي وقت مضي من أي رد فعل تحسسي على الجلد بعد العلاج بدواء مشابه لعقار ال بروتون الذي يقلل من حمض المعدة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا أصبت بطفح جلدي، خاصة في المناطق المعرضة للشمس، أخبر طبيبك في أقرب وقت ممكن، حيث قد تحتاج إلى إيقاف علاجك ب بروتون. تذكر أيضًا ذكر أي أعراض مرضية أخرى مثل الألم في مفاصلك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان من المقرر لك إجراء فحص دم معين (كرُومُوجْرانين أ).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أخبر طبيبك المعالج فورا</strong><strong>،</strong> قبل أو بعد تناول هذا الدواء، إذا لاحظت أيًا من الأعراض التالية، والتي قد تكون علامة على مرض آخر أكثر خطورة:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان غير متعمد للوزن.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تقيؤ، خاصة إذا تكرر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تقيؤ دموي؛ قد يظهر هذا في القيء في صورة مماثلة لحبيبات القهوة الداكنة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لاحظت وجود دم في برازك؛ والذي قد يكون أسود أو قطراني في المظهر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة في البلع أو الألم عند البلع.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تبدو شاحبًا وتشعر بالضعف (فقر الدم).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في الصدر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في المعدة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إسهال حاد و/أو مستمر، حيث قد يصاحب استخدام بروتون 20 ملجم زيادة طفيفة في الإسهال المعدي.</p><p dir="RTL">قد يقرر طبيبك المعالج بأنك تحتاج إلى بعض الفحوصات لاستبعاد مرض خبيث حيث أن بروتون أيضا قد يخفف من أعراض مرض السرطان، ويمكن أن يتسبب في تأخير تشخيص المرض.</p><p dir="RTL">فى حالة استمرار الأعراض لديك بالرغم من تناول العلاج سيتم النظر فى إجراء مزيد من الفحوصات.</p><p dir="RTL">فى حال تناولك لأقراص بروتون 20 ملجم كعلاج طويل المدى (لفترة أكثر من سنة) قد يلجأ طبيبك المعالج إلى وضعك تحت المراقبة بشكل منتظم. يجب عليك إبلاغ طبيبك المعالج كلما رأيته بأى أعراض وظروف جديدة واستثنائية.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الأطفال والمراهقين</strong><br />لا ينصح باستخدام بروتون 20 ملجم في الأطفال لأنه لم تثبت إمكانية استخدامه علي الأطفال دون سن 12 سنة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تناول أدوية أخرى:</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول، أو تناولت مؤخرا أو قد تتناول أي أدوية أخرى، بما في ذلك الأدوية التي يتم الحصول عليها دون وصفة طبية.<br /><br />هذا لأن بروتون 20 ملجم قد يؤثر على فعالية الأدوية الأخرى، لذلك أخبر طبيبك إذا كنت تتناول:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية مثل كيتوكونازول، إتراكونازول وبوساكونازول (والتي تستخدم لعلاج العدوى الفطرية) أو إيرلوتينيب (والذي يستخدم لعلاج بعض أنواع السرطان) لأن بروتون 20 ملجم قد يمنع هذه الأدوية وغيرها من العمل بشكل فعال.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وارفارين وفينبروكومون، والذي يؤثر على لزوجة الدم. فقد تحتاج إلى مزيد من الفحوصات.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة لعلاج عدوى فيروس نقص المناعة البشرية، مثل أتازانافير.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;الميثوتريكسيت (المستخدم لعلاج التهاب المفاصل الروماتويدي والصدفية والسرطان) - إذا كنت تتناول الميثوتريكسيت، فقد يوقف طبيبك علاجك باستخدام ال بروتون 20 ملجم مؤقتًا لأن البانتوبرازول يمكن أن يرفع من مستويات الميثوتريكسيت في الدم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فلوفوكسامين (المستخدم لعلاج الاكتئاب وأمراض نفسية أخرى) - إذا كنت تتناول فلوفوكسامين، فقد يخفض طبيبك الجرعة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;ريفامبيسين (المستخدم لعلاج العدوي).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نبتة سانت جون (عشبة القديس) (المستخدمة لعلاج الاكتئاب الطفيف).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL">لا توجد معلومات كافية حول استخدام البانتوبرازول للسيدات الحوامل. تم إصدار تقارير عن إفراز البانتوبرازول في لبن الام.<br /><br />إذا كنت حاملاً أو مرضعة، أو تعتقدين بأنك حاملاً، أو تخططين لإنجاب طفل، فاستشر طبيبك أو الصيدلي قبل تناول هذا الدواء.<br /><br />يجب أن تستخدمي هذا الدواء فقط إذا اعتبر طبيبك أن الفائدة بالنسبة لك أكبر من المخاطر المحتملة لطفلك أو الرضيع الذي لم يولد بعد.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">بروتون 20 ملجم ليس له أي تأثير يذكر على القدرة على القيادة أو استخدام الآلات.</p><p dir="RTL">إذا تعرضت لأعراض جانبية مثل الدوخة أو اضطراب الرؤية، يجب عليك عدم القيادة أو استخدام الآلات.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">قم دائما بتناول بروتون 20 ملجم تماما كما أخبرك طبيبك المعالج. إذا كنت غير واثق، يجب عليك التأكد من خلال طبيبك المعالج أو الصيدلى.</p><p dir="RTL">طريقة الاستخدام</p><p dir="RTL">تناول الأقراص قبل وجبة الطعام بساعة واحدة، بدون مضغ أو تكسير للقرص، وقم بابتلاع القرص كاملا مع بعض الماء.</p><p dir="RTL">الجرعة الموصي بها هي:</p><p dir="RTL"><strong>فى حالة البالغين والمراهقين فى سن 12 سنة فما أكثر</strong>:</p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>لعلاج الأعراض مثل (حرقة المعدة، ارتجاع الحامض، الألم المصاحب للبلع) المرتبطة بمرض الارتجاع المعدى المريئى </strong></p><p dir="RTL">تكون الجرعة المعتادة هى قرص واحد يوميا. هذه الجرعة عادة تزيل الأعراض فى خلال 2- 4 أسابيع &ndash; وفى الغالب بعد 4 أسابيع أخرى. وسوف يخبرك طبيبك المعالج بالفترة الزمنية اللازمة لاستمرار تناولك لهذا الدواء. بعد ذلك يمكن السيطرة على أى أعراض متكررة من خلال <strong>تناول قرص واحد فى اليوم</strong> عندما تقتضي الحاجة إلى ذلك.</p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>كعلاج طويل المدى للسيطرة والحد من تكرار الإصابة بالتهاب المرئ الناتج عن الارتجاع</strong></p><p dir="RTL">تكون الجرعة المعتادة هى قرص واحد يوميا. وفى حالة عودة المرض مرة أخرى قد يقوم طبيبك المعالج بمضاعفة الجرعة، في هذه الحالة يمكنك استخدام أقراص بروتون 40 ملجم قرص واحد مرة واحدة يوميا. وبعد الشفاء يمكنك خفض الجرعة مرة أخرى إلى قرص واحد من بروتون 20 ملجم مرة واحدة يوميا.</p><p dir="RTL"><strong>فى حالة البالغين</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>لمنع الإصابة بتقرحات المعدة والإثنى عشر فى حالة المرضى المحتاجين لتناول </strong>NSAIDs<strong> بشكل مستمر</strong></p><p dir="RTL">تكون الجرعة المعتادة هى قرص واحد يوميا.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>المرضى الذين يعانون من مشاكل في الكبد</strong><br />إذا كنت تعاني من مشاكل حادة في الكبد، يجب ألا تتناول أكثر من قرص واحد 20 ملجم يوميًا.<br /><br />&nbsp;</p><p dir="RTL"><strong>الاستخدام في الأطفال والمراهقين</strong><br />لا ينصح باستخدام هذه الأقراص&nbsp; للأطفال دون سن 12 سنة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>في حالة تناول أقراص بروتون 20 ملجم أكثر مما ينبغي</strong></p><p dir="RTL">أخبر طبيبك المعالج أو الصيدلي. حيث لا توجد أعراض معروفة للجرعة المفرطة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>في حالة نسيان تناول أقراص بروتون 20 ملجم</strong></p><p dir="RTL">لا تقم بمضاعفة الجرعة لتعويض الجرعة المفقودة. قم بتناول الجرعة التالية بشكل طبيعي في الوقت المعتاد.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>في حالة التوقف عن تناول أقراص بروتون 20 ملجم</strong></p><p dir="RTL">لا تتوقف عن تناول العلاج بتلك الأقراص بدون استشارة طبيبك المعالج أو الصيدلي أولا.</p><p dir="RTL">إذا كانت لديك أية أسئلة إضافية حول استخدام هذا الدواء، فضلا اسأل طبيبك المعالج أو الصيدلي أو الممرضة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، بروتون 20 ملجم قد يسبب أعراض جانبية، وإن لم تكن تحدث لكل من يتناول هذا الدواء.</p><p dir="RTL"><strong>إذا تعرضت لأي من الأعراض الجانبية الآتية، توقف عن تناول هذه الأقراص وأخبر طبيبك المعالج في الحال، أو توجه إلى قسم الإصابات في أقرب مستشفى:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>تفاعلات تحسسية حادة (</strong><strong>نادرة التكرار: </strong>قد تؤثر على 1 من كل 1000 شخص<strong>):</strong> تورم اللسان و/أو الحلق، صعوبة في البلع، الشرى (الحمي القراصية)، صعوبة في التنفس، تورم الوجه (وذمة كوينك/ وذمة وعائية)، دوار حاد مع تسارع شديد في ضربات القلب وعرق غزير.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>حالات جلدية خطرة (معدل التكرار غير معلوم: </strong>لا يمكن تقدير التكرار من البيانات المتاحة<strong>):</strong> ظهور تقرحات في الجلد وتدهور سريع في صحتك العامة، ظهور تقرحات (وتشمل نزيف بسيط) في العينين، الأنف، الفم/الشفتين أو الأعضاء التناسلية (متلازمة ستيفنز جونسون، متلازمة لايل، حمامي متعددة الأشكال) والحساسية تجاه الضوء.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حالات أخرى خطيرة <strong>(معدل التكرار غير معلوم:</strong> لا يمكن تقدير التكرار من البيانات المتاحة<strong>): </strong>اصفرار الجلد أو اصفرار بياض العينين (تلف حاد في خلايا الكبد، اليرقان) أو حمى، طفح جلدي وتضخم الكليتين والمصحوب أحيانا بألم عند التبول وألم في أسفل الظهر (التهاب حاد في الكليتين) وربما يؤدي إلى الفشل الكلوي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أعراض جانبية أخرى وهي:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>شائعة</strong> (قد تؤثر على 1 من كل 10 أشخاص):</p><p dir="RTL">الاورام الحميدة في المعدة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>غير شائعة</strong> (قد تؤثر على 1 من كل 100 شخص):</p><p dir="RTL">صداع، دوخة، إسهال، شعور بالإعياء، تقيؤ، امتلاء وانتفاخ (غازات)، إمساك، جفاف الحلق، ألم بالبطن وعدم ارتياح، طفح جلدي، طفح ظاهر، ثوران وحكة، شعور بالضعف أو الإرهاق أو شعور عام بالسقم، اضطرابات بالنوم، كسر في الورك أو المعصم أو العمود الفقري.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>نادرة </strong>(قد تؤثر على 1 من كل 1000 شخص):</p><p dir="RTL">خلل أو فقدان تام لحاسة التذوق، اضطرابات في الرؤية مثل ضبابية الرؤية، الشرى، ألم بالمفاصل، آلام في العضلات، تغيرات في الوزن، ارتفاع درجة حرارة الجسم، تورم الأطراف (الوذمة الطرفية)، تفاعلات تحسسية، اكتئاب، تضخم الصدر عند الرجال.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>نادرة جدا</strong> (قد تؤثر على 1 من كل 10000 شخص):</p><p dir="RTL">ارتباك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; غير معلومة (لا يمكن تقدير التكرار من البيانات المتاحة):</p><p dir="RTL">هلوسة، ارتباك (خصوصا لدي المرضى ذوى تاريخ لهذه الأعراض)، انخفاض مستوى الصوديوم في الدم، انخفاض مستوى الماغنسيوم في الدم (انظر الفقرة 2)، الشعور بالوخز، ألم كوخز المسامير، ألم كوخز الإبر، وإحساس بالحرقة أو التنميل، والطفح الجلدي، وربما يصاحبه ألم في المفاصل، والتهاب في الأمعاء الغليظة، مما يسبب الإسهال المائي المستمر.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أعراض جانبية يمكن التعرف عليها من خلال اختبارات الدم:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>غير شائعة</strong> (قد تؤثر على 1 من كل 100 شخص):</p><p dir="RTL">ارتفاع في إنزيمات الكبد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>نادرة </strong>(قد تؤثر على 1 من كل 1000 شخص):</p><p dir="RTL">ارتفاع في نسبة البيليروبين، زيادة الدهون فى الدم، انخفاض حاد في خلايا الدم البيضاء الحبيبية المتنقلة، المصاحب للحمي الشديدة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>نادرة جدا</strong> (قد تؤثر على 1 من كل 10000 شخص):</p><p dir="RTL">انخفاض عدد الصفائح الدموية، والتي قد تسبب لك النزيف أو الكدمات بشكل أكثر من المعتاد، انخفاض عدد خلايا الدم البيضاء، مما قد يؤدى إلى زيادة معدل تكرار العدوى، مصحوبة بانخفاض غير طبيعي في عدد خلايا الدم الحمراء والبيضاء، وكذلك الصفائح الدموية.</p><p dir="RTL">إذا لاحظت أن أيا من هذه الأعراض الجانبية أصبح جسيما، أو إذا لاحظت ظهور أي أعراض جانبية لم ترد في هذه النشرة فيرجى منك أن تخبر طبيبك المعالج أو الصيدلي الذي تتعامل معه بشأنها.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الإبلاغ عن الأعراض الجانبية</strong></p><p dir="RTL">إذا ظهرت عليك أي أعراض جانبية، قم بالتحدث مع طبيبك أو الصيدلي أو الممرضة. ويشمل ذلك أي أعراض جانبية محتملة غير المُدرجة في هذه النشرة. يمكنك أيضا الإبلاغ عن الأعراض الجانبية مباشرة عبر المركز الوطني للتيقظ والسلامة الدوائية. يمكنك من خلال الإبلاغ عن الأعراض الجانبية أن تساعد في توفير المزيد من المعلومات حول سلامة هذا الدواء.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يُحفظ بعيداً عن متناول ونظر الأطفال.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يُحفظ في درجة حرارة أقل من 30 درجة مئوية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستعمل هذا الدواء بعد انتهاء تاريخ الصلاحية المدون على العبوة بعد EXP. وتاريخ الانتهاء يشير إلى أخر يوم في الشهر المذكور.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب عدم التخلص من الأدوية في مياه المجاري أو قمامة المنزل. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجتها. لأن هذه الاعتبارات ستعمل على حماية البيئة.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>علام يحتوي بروتون 20 ملجم:</strong></p><p dir="RTL">المادة الفعالة هى: بانتوبرازول.</p><p dir="RTL">يحتوي كل قرص مغلف معوياً على 20 ملجم بانتوبرازول (على هيئة بانتوبرازول صوديوم).</p><p dir="RTL">المواد الأخرى هى:</p><p dir="RTL">حشوة القرص:</p><p dir="RTL"><strong>حشوة القرص: </strong></p><p dir="RTL">مانيتول بب ، كروسبوفيدون ، كربونات الصوديوم ديكاهيدرات ، بوفيدون K-90 ، ستيرات الكالسيوم USP ، مياه نقية BP</p><p dir="RTL"><strong>غلاف القرص:</strong></p><p dir="RTL">هيدروكسي بروبيل ميثيل السليلوز ، بوفيدون K-25 ، ثاني أكسيد التيتانيوم ، أكسيد الحديد الأصفر ، بروبيلين غليكول ، ايدراجيت &nbsp;L30D &nbsp;، ثلاثي إيثيل السيترات USP ، تالك منقى ، ماء نقي BP</p><p dir="RTL"><strong>مادة الطلاء:</strong></p><p dir="RTL">شمع كرنوبا.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">قرص بروتون 20 ملجم: هو قرص مغلف معوياً بيضاوي، وثنائي التحدب، لونه بيج، سادة من كلا الجانبين. متوفر فى عبوات تحتوي على 14 و 28 قرصا.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>الدوائية</strong></p><p dir="RTL">مصنع الأدوية بالقصيم</p><p dir="RTL">المملكة العربية السعودية.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            سبتمبر 2023.                                         
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Proton 20 mg Enteric coated tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each enteric coated tablet contains:
20 mg of pantoprazole (equivalent to 21.15 mg pantoprazole sodium).
For a full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Enteric coated tablet
Beige coloured, oval, shallow biconvex, enteric coated tablet, plain on both sides.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Proton is indicated for use in adults and adolescents 12 years of age and above for:</p><p>&bull; Symptomatic gastro-oesophageal reflux disease.</p><p>&bull; Long-term management and prevention of relapse in reflux oesophagitis.</p><p>Proton is indicated for use in adults for:</p><p>&bull; Prevention of gastroduodenal ulcers induced by non-selective non-steroidal anti-inflammatory drugs (NSAIDs) in patients at risk with a need for continuous NSAID treatment (see section 4.4).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p><em>Adults and adolescents 12 years of age and above</em></p><p><u>Symptomatic gastro-oesophageal reflux disease</u></p><p>The recommended oral dose is one Proton 20 mg tablet per day. Symptom relief is generally accomplished within 2-4 weeks. If this is not sufficient, symptom relief will normally be achieved within a further 4 weeks. When symptom relief has been achieved, reoccurring symptoms can be controlled using an on-demand regimen of 20 mg once daily, taking one tablet when required. A switch to continuous therapy may be considered in case satisfactory symptom control cannot be maintained with on-demand treatment.</p><p><u>Long-term management and prevention of relapse in reflux oesophagitis</u></p><p>For long-term management, a maintenance dose of one Proton 20 mg tablet per day is recommended, increasing to 40 mg pantoprazole per day if a relapse occurs. Proton 40 mg tablet is available for this case. After healing of the relapse the dose can be reduced again to Proton 20 mg tablet.</p><p><em>Adults</em></p><p>Prevention of gastroduodenal ulcers induced by non-selective non-steroidal anti-inflammatory drugs (NSAIDs) in patients at risk with a need for continuous NSAID treatment</p><p>The recommended oral dose is one Proton 20 mg tablet per day.</p><p><em>Patients with hepatic impairment</em></p><p>A daily dose of 20 mg pantoprazole should not be exceeded in patients with severe liver impairment (see section 4.4).</p><p><em>Patients with renal impairment</em></p><p>No dose adjustment is necessary in patients with impaired renal function (see section 5.2).</p><p><em>Older people</em></p><p>No dose adjustment is necessary in older people (see section 5.2).</p><p><em>Paediatric population</em></p><p>Proton is not recommended for use in children below 12 years of age because of limited data on safety and efficacy in this age group (see section 5.2).</p><p><u>Method of administration</u></p><p>Oral use</p><p>The tablets should not be chewed or crushed, and should be swallowed whole 1 hour before a meal with some water.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance substituted benzimidazoles or to any of the excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Hepatic impairment</em></p><p>In patients with severe liver impairment the liver enzymes should be monitored regularly during treatment with pantoprazole, particularly on long-term use. In the case of a rise of the liver enzymes the treatment should be discontinued (see section 4.2).</p><p><em>Co-administration with NSAIDs</em></p><p>The use of Proton 20 mg as a preventive of gastroduodenal ulcers induced by non-selective non-steroidal anti-inflammatory drugs (NSAIDs) should be restricted to patients who require continued NSAID treatment and have an increased risk to develop gastrointestinal complications. The increased risk should be assessed according to individual risk factors, e.g. high age (&gt;65 years), history of gastric or duodenal ulcer or upper gastrointestinal bleeding.</p><p><em>Gastric malignancy</em></p><p>Symptomatic response to pantoprazole may mask the symptoms of gastric malignancy and may delay diagnosis. In the presence of any alarm symptom (e.g. significant unintentional weight loss, recurrent vomiting, dysphagia, haematemesis, anaemia or melaena) and when gastric ulcer is suspected or present, malignancy should be excluded.</p><p>Further investigation is to be considered if symptoms persist despite adequate treatment.</p><p><em>Co-administration with HIV protease inhibitors</em></p><p>Co-administration of pantoprazole is not recommended with HIV protease inhibitors for which absorption is dependent on acidic intragastric pH such as atazanavir, due to significant reduction in their bioavailability (see section 4.5).</p><p><em>Influence on vitamin B12 absorption</em></p><p>Proton, as all acid-blocking medicines, may reduce the absorption of vitamin B12 (cyanocobalamin) due to hypo- or achlorhydria. This should be considered in patients with reduced body stores or risk factors for reduced vitamin B12 absorption on long-term therapy or if respective clinical symptoms are observed.</p><p><em>Long term treatment</em></p><p>In long-term treatment, especially when exceeding a treatment period of 1 year, patients should be kept under regular surveillance.</p><p><em>Gastrointestinal infections caused by bacteria</em></p><p>Treatment with Proton may lead to a slightly increased risk of gastrointestinal infections caused by bacteria such as&nbsp;<em>Salmonella</em>&nbsp;and&nbsp;<em>Campylobacter</em>&nbsp;or&nbsp;<em>C. difficile</em>.</p><p><em>Hypomagnesaemia</em></p><p>Severe hypomagnesaemia has been reported in patients treated with PPIs like pantoprazole for at least three months, and in most cases for a year. Serious manifestations of hypomagnesaemia such as fatigue, tetany, delirium, convulsions, dizziness, and ventricular arrhythmia can occur but they may begin insidiously and be overlooked. In most affected patients, hypomagnesaemia improved after magnesium replacement and discontinuation of the PPI.</p><p>For patients expected to be on prolonged treatment or who take PPIs with digoxin or medicinal products that may cause hypomagnesaemia (e.g. diuretics), health care professionals should consider measuring magnesium levels before starting PPI treatment and periodically during treatment.</p><p><em>Bone fractures</em></p><p>Proton pump inhibitors, especially if used in high doses and over long durations (&gt;1 year), may modestly increase the risk of hip, wrist and spine fracture, predominantly in older people or in presence of other recognised risk factors. Observational studies suggest that proton pump inhibitors may increase the overall risk of fracture by 10&ndash;40%. Some of this increase may be due to other risk factors. Patients at risk of osteoporosis should receive care according to current clinical guidelines and they should have an adequate intake of vitamin D and calcium.</p><p><em>Subacute cutaneous lupus erythematosus (SCLE)</em></p><p>Proton pump inhibitors are associated with very infrequent cases of SCLE. If lesions occur, especially in sun exposed areas of the skin, and if accompanied by arthralgia, the patient should seek medical help promptly and the healthcare professional should consider stopping Proton. SCLE after previous treatment with a proton pump inhibitor may increase the risk of SCLE with other proton pump inhibitors.</p><p>Interference with Laboratory Tests</p><p>Increased Chromogranin A (CgA) level may interfere with investigations for neuroendocrine tumours. To avoid this interference, Proton treatment should be stopped for at least 5 days before CgA measurements (see section 5.1). If CgA and gastrin levels have not returned to reference range after initial measurement, measurements should be repeated 14 days after cessation of proton pump inhibitor treatment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em><u>Medicinal products with pH-Dependent Absorption Pharmacokinetics</u></em></p><p>Because of profound and long lasting inhibition of gastric acid secretion, pantoprazole may interfere with the absorption of other medicinal products where gastric pH is an important determinant of oral availability, e.g. some azole antifungals such as ketoconazole, itraconazole, posaconazole and other medicines such as erlotinib.</p><p><em><u>HIV protease inhibitors)</u></em></p><p>Co-administration of pantoprazole is not recommended with HIV protease inhibitors for which absorption is dependent on acidic intragastric pH such as atazanavir due to significant reduction in their bioavailability (see section 4.4).</p><p>If the combination of HIV protease inhibitors with a proton pump inhibitor is judged unavoidable, close clinical monitoring (e.g virus load) is recommended. A pantoprazole dose of 20 mg per day should not be exceeded. Dosage of the HIV protease inhibitor may need to be adjusted</p><p><em><u>Coumarin anticoagulants (phenprocoumon or warfarin)</u></em></p><p>Co-administration of pantoprazole with warfarin or phenprocoumon did not affect the pharmacokinetics of warfarin, phenprocoumon or INR. However, there have been reports of increased INR and prothrombin time in patients receiving PPIs and warfarin or phenprocoumon concomitantly. Increases in INR and prothrombin time may lead to abnormal bleeding, and even death. Patients treated with pantoprazole and warfarin or phenprocoumon may need to be monitored for increase in INR and prothrombin time.</p><p><em><u>Methotrexate</u></em></p><p>Concomitant use of high dose methotrexate (e.g. 300 mg) and proton-pump inhibitors has been reported to increase methotrexate levels in some patients. Therefore in settings where high-dose methotrexate is used, for example cancer and psoriasis, a temporary withdrawal of pantoprazole may need to be considered.</p><p><em><u>Other interactions studies</u></em></p><p>Proton is extensively metabolized in the liver via the cytochrome P450 enzyme system. The main metabolic pathway is demethylation by CYP2C19 and other metabolic pathways include oxidation by CYP3A4.</p><p>Interaction studies with medicinal products also metabolized with these pathways, like carbamazepine, diazepam, glibenclamide, nifedipine, and an oral contraceptive containing levonorgestrel and ethinyl oestradiol, did not reveal clinically significant interactions.</p><p>An interaction of pantoprazole with other medicinal products or compounds, which are metabolized using the same enzyme system, cannot be excluded.</p><p>Results from a range of interaction studies demonstrate that pantoprazole does not affect the metabolism of active substances metabolised by CYP1A2 (such as caffeine, theophylline), CYP2C9 (such as piroxicam, diclofenac, naproxen), CYP2D6 (such as metoprolol), CYP2E1 (such as ethanol), or does not interfere with p-glycoprotein related absorption of digoxin.</p><p>There were no interactions with concomitantly administered antacids.</p><p>Interaction studies have also been performed by concomitantly administering pantoprazole with the respective antibiotics (clarithromycin, metronidazole, amoxicillin). No clinically relevant interactions were found.</p><p>Medicinal products that inhibit or induce CYP2C19:</p><p>Inhibitors of CYP2C19 such as fluvoxamine could increase the systemic exposure of pantoprazole. A dose reduction may be considered for patients treated long-term with high doses of pantoprazole, or those with hepatic impairment.</p><p>Enzyme inducers affecting CYP2C19 and CYP3A4 such as rifampicin and St John&acute;s wort (<em>Hypericum perforatum</em>) may reduce the plasma concentrations of PPIs that are metabolized through these enzyme systems.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>A moderate amount of data on pregnant women (between 300-1000 pregnancy outcomes) indicate no malformative or feto/ neonatal toxicity of Proton.</p><p>Animal studies have shown reproductive toxicity (see section 5.3).</p><p>As a precautionary measure, it is preferable to avoid the use of Proton during pregnancy.</p><p><u>Breast-feeding</u></p><p>Animal studies have shown excretion of pantoprazole in breast milk. There is insufficient information on the excretion of pantoprazole in human milk but excretion into human milk has been reported. A risk to the newborns/infants cannot be excluded. Therefore, a decision on whether to discontinue breast-feeding or to discontinue/abstain from Proton therapy should take into account the benefit of breast-feeding for the child, and the benefit of Proton therapy for the woman.</p><p><u>Fertility</u></p><p>There was no evidence of impaired fertility following the administration of pantoprazole in animal studies (see section 5.3).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Proton has no or negligible influence on the ability to drive and use machines.</p><p>Adverse drug reactions, such as dizziness and visual disturbances may occur (see section 4.8). If affected, patients should not drive or operate machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Approximately 5 % of patients can be expected to experience adverse drug reactions (ADRs). The most commonly reported ADRs are diarrhoea and headache, both occurring in approximately 1 % of patients.</p><p>The table below lists adverse reactions reported with pantoprazole, ranked under the following frequency classification:</p><p>Very common (&ge;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000 to &lt;1/100); rare (&ge;1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000), not known (cannot be estimated from the available data).</p><p>For all adverse reactions reported from post-marketing experience, it is not possible to apply any Adverse Reaction frequency and therefore they are mentioned with a &ldquo;not known&rdquo; frequency.</p><p>Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.</p><p>Table 1. Adverse reactions with pantoprazole in clinical trials and post-marketing experience</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p><strong>Frequency</strong></p></td><td rowspan="2"><p><strong>Common</strong></p></td><td rowspan="2"><p><strong>Uncommon</strong></p></td><td rowspan="2"><p><strong>Rare</strong></p></td><td rowspan="2"><p><strong>Very rare</strong></p></td><td rowspan="2"><p><strong>Not known</strong></p></td></tr><tr><td><p><strong>System Organ Class</strong></p></td></tr><tr><td><p>Blood and lymphatic system disorders</p></td><td>&nbsp;</td><td>&nbsp;</td><td><p>Agranulocytosis</p></td><td><p>Thrombocytopenia; Leukopenia; Pancytopenia</p></td><td>&nbsp;</td></tr><tr><td><p>Immune system disorders</p></td><td>&nbsp;</td><td>&nbsp;</td><td><p>Hypersensitivity (including anaphylactic reactions and anaphylactic shock)</p></td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td><p>Metabolism and nutrition disorders</p></td><td>&nbsp;</td><td>&nbsp;</td><td><p>Hyperlipidaemias and lipid increases (triglycerides, cholesterol); Weight changes</p></td><td>&nbsp;</td><td><p>Hyponatraemia; Hypomagnesaemia (see section 4.4); Hypocalcaemia&nbsp;<sup>(1)</sup>; Hypokalaemia</p></td></tr><tr><td><p>Psychiatric disorders</p></td><td>&nbsp;</td><td><p>Sleep disorders</p></td><td><p>Depression (and all aggravations)</p></td><td><p>Disorientation (and all aggravations)</p></td><td><p>Hallucination; Confusion (especially in pre-disposed patients, as well as the aggravation of these symptoms in case of pre-existence)</p></td></tr><tr><td><p>Nervous system disorders</p></td><td>&nbsp;</td><td><p>Headache; Dizziness</p></td><td><p>Taste disorders</p></td><td>&nbsp;</td><td><p>Parasthesia</p></td></tr><tr><td><p>Eye disorders</p></td><td>&nbsp;</td><td>&nbsp;</td><td><p>Disturbances in vision / blurred vision</p></td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td><p>Gastrointestinal disorders</p></td><td><p>Fundic gland polyps (benign)</p></td><td><p>Diarrhoea; Nausea / vomiting; Abdominal distension and bloating; Constipation; Dry mouth; Abdominal pain and discomfort</p></td><td>&nbsp;</td><td>&nbsp;</td><td><p>Microscopic colitis</p></td></tr><tr><td><p>Hepatobiliary disorders</p></td><td>&nbsp;</td><td><p>Liver enzymes increased (transaminases, &gamma;-GT)</p></td><td><p>Bilirubin increased</p></td><td>&nbsp;</td><td><p>Hepatocellular injury; Jaundice; Hepatocellular failure</p></td></tr><tr><td><p>Skin and sub-cutaneous tissue disorders</p></td><td>&nbsp;</td><td><p>Rash / exanthema / eruption; Pruritus</p></td><td><p>Urticaria; Angioedema</p></td><td>&nbsp;</td><td><p>Stevens-Johnson syndrome; Lyell syndrome; Erythema multiforme; Photosensitivity; Subacute cutaneous lupus erythematosus (see section 4.4)</p></td></tr><tr><td><p>Musculoskeletal and connective tissue disorders</p></td><td>&nbsp;</td><td><p>Fracture of the hip, wrist or spine (see section 4.4)</p></td><td><p>Arthralgia; Myalgia</p></td><td>&nbsp;</td><td><p>Muscle spasm&nbsp;<sup>(2)</sup></p></td></tr><tr><td><p>Renal and urinary disorders</p></td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td><p>Interstitial nephritis (with possible progression to renal failure)</p></td></tr><tr><td><p>Reproductive system and breast disorders</p></td><td>&nbsp;</td><td>&nbsp;</td><td><p>Gynaecomastia</p></td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td><p>General disorders and administration site conditions</p></td><td>&nbsp;</td><td><p>Asthenia, fatigue and malaise</p></td><td><p>Body temperature increased; Oedema peripheral</p></td><td>&nbsp;</td><td>&nbsp;</td></tr></tbody></table><p><sup>1.&nbsp;</sup>Hypocalcemia in association with hypomagnesemia</p><p><sup>2.&nbsp;</sup>Muscle spasm as a consequence of electrolyte disturbance</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via:</p><p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p><strong>To report any side effect(s):</strong></p><p> The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>o Fax: +966-11-205-7662</p><p>o Call NPC at +966-11-2038222, Exts: 2317-2356-2340.</p><p>o Reporting hotline: 19999.</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: www.sfda.gov.sa/npc</p><p>&nbsp;</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no known symptoms of overdose in man.</p><p>Systemic exposure with up to 240 mg administered intravenously over 2 minutes, were well tolerated.</p><p>As pantoprazole is extensively protein bound, it is not readily dialysable.</p><p>In the case of an overdose with clinical signs of intoxication, apart from symptomatic and supportive treatment, no specific therapeutic recommendations can be made.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Proton pump inhibitors, ATC code: A02BC02</p><p><u>Mechanism of action</u></p><p>Proton is a substituted benzimidazole which inhibits the secretion of hydrochloric acid in the stomach by specific blockade of the proton pumps of the parietal cells.</p><p>Proton is converted to its active form in the acidic environment in the parietal cells where it inhibits the H+, K+-ATPase enzyme, i.e. the final stage in the production of hydrochloric acid in the stomach. The inhibition is dose-dependent and affects both basal and stimulated acid secretion. In most patients, freedom from symptoms is achieved within 2 weeks. As with other proton pump inhibitors and H2 receptor inhibitors, treatment with pantoprazole reduces acidity in the stomach and thereby increases gastrin in proportion to the reduction in acidity. The increase in gastrin is reversible. Since pantoprazole binds to the enzyme distal to the cell receptor level, it can inhibit hydrochloric acid secretion independently of stimulation by other substances (acetylcholine, histamine, gastrin). The effect is the same whether the product is given orally or intravenously.</p><p><u>Pharmacodynamic effects</u></p><p>The fasting gastrin values increase under pantoprazole. On short-term use, in most cases they do not exceed the upper limit of normal. During long-term treatment, gastrin levels double in most cases. An excessive increase, however, occurs only in isolated cases. As a result, a mild to moderate increase in the number of specific endocrine (ECL) cells in the stomach is observed in a minority of cases during long-term treatment (simple to adenomatoid hyperplasia). However, according to the studies conducted so far, the formation of carcinoid precursors (atypical hyperplasia) or gastric carcinoids as were found in animal experiments (see section 5.3) have not been observed in humans.</p><p>An influence of a long term treatment with pantoprazole exceeding one year cannot be completely ruled out on endocrine parameters of the thyroid according to results in animal studies.</p><p>During treatment with antisecretory medicinal products, serum gastrin increases in response to the decreased acid secretion. Also CgA increases due to decreased gastric acidity. The increased CgA level may interfere with investigations for neuroendocrine tumours.</p><p>Available published evidence suggests that proton pump inhibitors should be discontinued between 5 days and 2 weeks prior to CgA measurements. This is to allow CgA levels that might be spuriously elevated following PPI treatment to return to reference range.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u></p><p>Proton is rapidly absorbed and the maximal plasma concentration is achieved even after one single 20 mg oral dose. On average at about 2.0 h - 2.5 h p.a. the maximum serum concentrations of about 1-1.5 &micro;g/ml are achieved, and these values remain constant after multiple administration. Pharmacokinetics does not vary after single or repeated administration. In the dose range of 10 to 80 mg, the plasma kinetics of pantoprazole are linear after both oral and intravenous administration.</p><p>The absolute bioavailability from the tablet was found to be about 77 %. Concomitant intake of food had no influence on AUC, maximum serum concentration and thus bioavailability. Only the variability of the lag-time will be increased by concomitant food intake.</p><p><u>Distribution</u></p><p>Proton&#39;s serum protein binding is about 98 %. Volume of distribution is about 0.15 l/kg.</p><p><u>Biotransformation</u></p><p>The substance is almost exclusively metabolized in the liver. The main metabolic pathway is demethylation by CYP2C19 with subsequent sulphate conjugation; other metabolic pathway includes oxidation by CYP3A4.</p><p><u>Elimination</u></p><p>Terminal half-life is about 1 hour and clearance is about 0.1 l/h/kg. There were a few cases of subjects with delayed elimination. Because of the specific binding of pantoprazole to the proton pumps of the parietal cell the elimination half-life does not correlate with the much longer duration of action (inhibition of acid secretion).</p><p>Renal elimination represents the major route of excretion (about 80 %) for the metabolites of pantoprazole, the rest is excreted with the faeces. The main metabolite in both the serum and urine is desmethylpantoprazole which is conjugated with sulphate. The half-life of the main metabolite (about 1.5 hours) is not much longer than that of pantoprazole.</p><p><u>Special populations</u></p><p><em>Poor metabolisers</em></p><p>Approximately 3 % of the European population lack a functional CYP2C19 enzyme and are called poor metabolisers. In these individuals the metabolism of pantoprazole is probably mainly catalysed by CYP3A4. After a single-dose administration of 40 mg pantoprazole, the mean area under the plasma concentration-time curve was approximately 6 times higher in poor metabolisers than in subjects having a functional CYP2C19 enzyme (extensive metabolisers). Mean peak plasma concentrations were increased by about 60 %. These findings have no implications for the posology of pantoprazole.</p><p><em>Renal impairment</em></p><p>No dose reduction is recommended when pantoprazole is administered to patients with impaired renal function (including dialysis patients). As with healthy subjects, pantoprazole&#39;s half-life is short. Only very small amounts of pantoprazole are dialyzed. Although the main metabolite has a moderately delayed half-life (2 - 3h), excretion is still rapid and thus accumulation does not occur.</p><p><em>Hepatic impairment</em></p><p>Although for patients with liver cirrhosis (classes A and B according to Child) the half-life values increased to between 3 and 6 h and the AUC values increased by a factor of 3 - 5, the maximum serum concentration only increased slightly by a factor of 1.3 compared with healthy subjects.</p><p><em>Older people</em></p><p>A slight increase in AUC and C<sub>max</sub>&nbsp;in elderly volunteers compared with younger counterparts is also not clinically relevant.</p><p><em>Paediatric population</em></p><p>Following administration of single oral doses of 20 or 40 mg pantoprazole to children aged 5 - 16 years AUC and C<sub>max</sub>&nbsp;were in the range of corresponding values in adults.</p><p>Following administration of single i.v. doses of 0.8 or 1.6 mg/kg pantoprazole to children aged 2 - 16 years there was no significant association between pantoprazole clearance and age or weight. AUC and volume of distribution were in accordance with data from adults.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazard to humans based on conventional studies of safety pharmacology, repeated dose toxicity and genotoxicity.</p><p>In the two-year carcinogenicity studies in rats neuroendocrine neoplasms were found. In addition, squamous cell papillomas were found in the fore stomach of rats. The mechanism leading to the formation of gastric carcinoids by substituted benzimidazoles has been carefully investigated and allows the conclusion that it is a secondary reaction to the massively elevated serum gastrin levels occurring in the rat during chronic high-dose treatment. In the two-year rodent studies an increased number of liver tumours was observed in rats and in female mice and was interpreted as being due to pantoprazole&#39;s high metabolic rate in the liver.</p><p>A slight increase of neoplastic changes of the thyroid was observed in the group of rats receiving the highest dose (200 mg/kg). The occurrence of these neoplasms is associated with the pantoprazole-induced changes in the breakdown of thyroxine in the rat liver. As the therapeutic dose in man is low, no harmful effects on the thyroid glands are expected.</p><p>In a peri-postnatal rat reproduction study designed to assess bone development, , signs of offspring toxicity (mortality, lower mean body weight, lower mean body weight gain and reduced bone growth) were observed at exposures (C<sub>max</sub>) approximately 2x the human clinical exposure. By the end of the recovery phase, bone parameters were similar across groups and body weights were also trending toward reversibility after a drug-free recovery period. The increased mortality has only been reported in pre-weaning rat pups (up to 21 days age) which is estimated to correspond to infants up to the age of 2 years old. The relevance of this finding to the paediatric population is unclear. A previous peri-postnatal study in rats at slightly lower doses found no adverse effects at 3 mg/kg compared with a low dose of 5 mg/kg in this study.</p><p>Investigations revealed no evidence of impaired fertility or teratogenic effects.</p><p>Penetration of the placenta was investigated in the rat and was found to increase with advanced gestation. As a result, concentration of pantoprazole in the foetus is increased shortly before birth.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Excipients</strong></p><p>Mannitol BP, Crospovidone NF, Sodium Carbonate Decahydrate BP, Povidone K-90, Calcium Stearate USP.</p><p><strong>Seal Coating</strong></p><p>Hydroxypropyl Methyl Cellulose, Povidone K-25, Titanium Dioxide, Iron Oxide Yellow, Propylene Glycol.</p><p><strong>Enteric Coating</strong></p><p>Eudragit L30D&nbsp; (30% SOLN), Triethyl Citrate USP, Purified Talc, Purified Water BP&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p><strong>Polishing</strong></p><p>Carnauba Wax.</p><p><strong>&nbsp;</strong></p><p><strong>Pantoprazole sodium is dispensed based on the potency and the difference is compensated mannitol BP.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36Months/3Years 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>14 and 28/pack</p><p>Reel PVC/PVDC and aluminium foil lid</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                SPIMACO 
Al-Qassim Pharmaceutical Plant.
Saudi Arabia.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                September 2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>